A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...

What if scientists could build a realistic model of the human lung, not full-sized, but grown in the lab from living cells?

Mucosal antigen-specific T cells are pivotal for pathogen clearance and immune modulation in respiratory infections. Dysregulated T cell responses exacerbate coronavirus disease 2019 severity, marked ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19.

Approximately 15 to 20 million Americans who have acquired COVID-19 experience persistent symptoms lasting over 3 months (long-COVID). Respiratory symptoms of long-COVID include breathlessness, ...

Multiple sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infections have been associated with neurological complications that are potentially attributed to direct ...

Scientists have already run studies to show the effect vaping has on the lungs, but now a professor explains the habit 'opens ...

COVID-19 causes a severe cytokine storm leading to excessive inflammation of organs. Iguratimod—a safe drug already in use for treating rheumatoid arthritis—suppresses excessive inflammation caused by ...

Researchers at the University of Colorado (CU) Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center (MECCC), and Utrecht University have found what they suggest is the first direct ...